综合色婷婷,国产精品 精品国内自产拍,a一级一片一级二级,无码少妇一区二区浪潮免费

加入收藏 | 設(shè)為首頁 | 聯(lián)系我們

產(chǎn)品搜索

相關(guān)文章

聯(lián)系我們

聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com

產(chǎn)品展示 / PRODUCTS
藥靶細胞株 > kinase激酶細胞株 > CBP73364EML4-ALK V1 C1156Y/G1202R/BaF3 kinase

EML4-ALK V1 C1156Y/G1202R/BaF3 kinase
名稱 EML4-ALK V1 C1156Y/G1202R/BaF3 kinase
型號 CBP73364
報價
特點 EML4-ALK V1 [C1156Y/G1202R]/BaF3
  • 詳細內(nèi)容
CBP73364
I. Introduction

Cell Line Name:

EML4-ALK V1 [C1156Y/G1202R]/BaF3

Host Cell:

Ba/F3

Stability:16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)

Application:

Anti-proliferation assay and PD assay

Freeze Medium:

90% FBS+10% DMSO

Complete Culture Medium:

RPMI-1640+10%FBS

Mycoplasma Status:

Negative

 
II.Background

Approximately 3–7% of lung tumors harbor ALK fusions (Koivunen et al. 2008; Kwak et al. 2010; Shinmura et al. 2008; Soda et al. 2007; Takeuchi et al. 2008; Wong et al. 2009). ALK fusions are more commonly found in light smokers (< 10 pack years) and/or never-smokers (Inamura et al. 2009; Koivunen et al. 2008; Kwak et al. 2010; Soda et al. 2007; Wong et al. 2009). ALK fusions are also associated with younger age (Inamura et al. 2009; Kwak et al. 2010; Wong et al. 2009) and adenocarcinomas with acinar histology (Inamura et al. 2009; Wong et al. 2009) or signet-ring cells (Kwak et al. 2010). Clinically, the presence of EML4-ALK fusions is associated with EGFR tyrosine kinase inhibitor (TKI) resistance (Shaw et al. 2009).

Multiple different ALK rearrangements have been described in NSCLC. The majority of these ALK fusion variants are comprised of portions of the echinoderm microtubule-associated protein-like 4 (EML4) gene with the ALK gene. At least nine different EML4-ALK fusion variants have been identified in NSCLC (Figure 1; Choi et al. 2008; Horn and Pao 2009; Koivunen et al. 2008; Soda et al. 2007; Takeuchi et al. 2008; Takeuchi et al. 2009; Wong et al. 2009). In addition, non-EML4 fusion partners have also been identified, including KIF5B-ALK (Takeuchi et al. 2009) and TFG-ALK (Rikova et al. 2007). Clinically, the presence of an ALK rearrangement is detected by fluorescence in situ hybridization (FISH) with an ALK break apart probe. FISH testing is not able to discern which particular ALK fusion is found in a clinical sample.

 
III. Representative Data

1. Sanger of EML4-ALK V1 [C1156Y/G1202R]/BaF3

CBP73364 sanger-C1156Y.png


Figure 1. EML4-ALK V1 [C1156Y/G1202R]/BaF3 C1156Y

CBP73364 sanger-G1202R.png

Figure 2.  EML4-ALK V1 [C1156Y/G1202R]/BaF3 G1202R 

CBP73364 sanger-Fusion.png


Figure 3. EML4-ALK V1 [C1156Y/G1202R]/BaF3 Fusion

 

2. Anti-proliferation assay

CBP73364 數(shù)據(jù)圖.png

Figure 4. CTG Proliferation Assay of BaF3 EML4-ALK V1 [C1156Y/G1202R] (C1).

 

 

" _ue_custom_node_="true">

如果你對CBP73364EML4-ALK V1 C1156Y/G1202R/BaF3 kinase感興趣,想了解更詳細的產(chǎn)品信息,填寫下表直接與廠家聯(lián)系:


留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結(jié)果(填寫阿拉伯數(shù)字),如:三加四=7

化工儀器網(wǎng)

推薦收藏該企業(yè)網(wǎng)站